Roman Lapshin

Dr. Roman Lapshin

Privolzhsky Research Medical University
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
VKVasily A. Kudinov
Vasily A. Kudinov
Rafael ArtyushevRafael Artyushev
Rafael Artyushev
IZIrina Zurina
Irina Zurina
RLRoman Lapshin
Roman Lapshin
LSLudmila B. Snopova
Ludmila B. Snopova
ISIrina N. Saburina
Irina N. Saburina
Background: There is a need for better strategies to promote burn wound healing and prevent infection. The aim of our study was to develop an easy-to-use placental multipotent mesenchymal stromal cell (MMSC) secretome-based chitosan hydrogel (MSC-Ch-gel) and estimate its antimicrobial and regenerative activity in Staphylococcus aureus-infected burn wounds in rats. Methods: Proteomic studies of the MMSC secretome revealed proteins involved in regeneration, angiogenesis, and defence responses. The MMSC secretome was collected from cultured cells and mixed with water-soluble chitosan to prepare the placental MSC-Ch-gel, which was stored in liquid phase at 4 °C. The wounds of rats with established II-IIIa-degree burns were then infected with S. aureus and externally covered with the MSC-Ch-gel. Three additional rat groups were treated with medical Vaseline oil, the antiseptic drug Miramistin®, or the drug Bepanthen® Plus. Skin wound samples were collected 4 and 8 days after burning for further microbiological and histological analysis. Blood samples were also collected for biochemical analysis. Results: Application of the MSC-Ch-gel cleared the wound of microorganisms (S. aureus wasn’t detected in the washings from the burned areas), decreased inflammation, enhanced re-epithelialisation, and promoted the formation of well-vascularised granulation tissue. Conclusions: MSC-Ch-gel effectively promotes infected wound healing in rats with third-degree burns. Gel preparation can be easily implemented into clinical practice.

Verified
Journal Article
Open access
PDF file
VKVasily A. Kudinov
Vasily A. Kudinov
Rafael ArtyushevRafael Artyushev
Rafael Artyushev
IZIrina Zurina
Irina Zurina
EZElena Zorina
Elena Zorina
RLRoman Lapshin
Roman Lapshin
ISIrina N. Saburina
Irina N. Saburina
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is a common clinical problem, leading to significant morbidity and mortality, and no effective pharmacotherapy exists. The problem of ARDS causing mortality became more apparent during the COVID-19 pandemic. Biotherapeutic products containing multipotent mesenchymal stromal cell (MMSC) secretome may provide a new therapeutic paradigm for human healthcare due to their immunomodulating and regenerative abilities. The content and regenerative capacity of the secretome depends on cell origin and type of cultivation (two- or three-dimensional (2D/3D)). In this study, we investigated the proteomic profile of the secretome from 2D- and 3D-cultured placental MMSC and lung fibroblasts (LFBs) and the effect of inhalation of freeze-dried secretome on survival, lung inflammation, lung tissue regeneration, fibrin deposition in a lethal ALI model in mice. We found that three inhaled administrations of freeze-dried secretome from 2D- and 3D-cultured placental MMSC and LFB protected mice from death, restored the histological structure of damaged lungs, and decreased fibrin deposition. At the same time, 3D MMSC secretome exhibited a more pronounced trend in lung recovery than 2D MMSC and LFB-derived secretome in some measures. Taking together, these studies show that inhalation of cell secretome may also be considered as a potential therapy for the management of ARDS in patients suffering from severe pneumonia, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), however, their effectiveness requires further investigation.

1 March 2016 in Sovremennye tehnologii v medicine
Verified
Journal Article
Closed access
DRD.A. Ryabova
D.A. Ryabova
NONatalia Orlinskaya
Natalia Orlinskaya
STS.N. Tsybusov
S.N. Tsybusov
NHN.E. Homutinnikova
N.E. Homutinnikova
RLRoman Lapshin
Roman Lapshin
EDE.A. Durnovo
E.A. Durnovo

1 March 2017 in Sovremennye tehnologii v medicine
Verified
Journal Article
Closed access
EME.V. Mitroshina
E.V. Mitroshina
BAB.Zh. Abogessimengane
B.Zh. Abogessimengane
URUrazov
Urazov
IHI. Hamraoui
I. Hamraoui
Tatiana A. MishchenkoTatiana A. Mishchenko
Tatiana A. Mishchenko
MVMaria V. Vedunova
Maria V. Vedunova

1 September 2016 in Sovremennye tehnologii v medicine
Verified
Journal Article
Closed access
МGМ.V. Galkina
М.V. Galkina
LSL.B. Snopova
L.B. Snopova
NPN.N. Prodanets
N.N. Prodanets
RLRoman Lapshin
Roman Lapshin
IBI.I. Belousova
I.I. Belousova
MBMarina Bugrova
Marina Bugrova

1 June 2015 in Sovremennye tehnologii v medicine
Verified
Journal Article
Closed access
AKA.E. Kukharenko
A.E. Kukharenko
ABA.A. Babaev
A.A. Babaev
NSN.A. Shchelchkova
N.A. Shchelchkova
RLRoman Lapshin
Roman Lapshin
MVMaria V. Vedunova
Maria V. Vedunova
LLL.V. Lovtsova
L.V. Lovtsova